GoodRx Holdings, Inc.
NASDAQ:GDRX
4.42 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 792.324 | 750.265 | 766.554 | 745.424 | 550.7 | 388.224 | 249.522 | 157.24 | 99.377 |
| Cost of Revenue
| 48.215 | 66.925 | 65.079 | 46.716 | 29.587 | 14.016 | 6.035 | 12.174 | 10.319 |
| Gross Profit
| 744.109 | 683.34 | 701.475 | 698.708 | 521.113 | 374.208 | 243.487 | 145.066 | 89.058 |
| Gross Profit Ratio
| 0.939 | 0.911 | 0.915 | 0.937 | 0.946 | 0.964 | 0.976 | 0.923 | 0.896 |
| Reseach & Development Expenses
| 123.749 | 135.836 | 143.137 | 125.86 | 61.816 | 29.3 | 43.894 | 11.501 | 5.742 |
| General & Administrative Expenses
| 117.862 | 125.515 | 144.792 | 154.686 | 461.451 | 14.692 | 8.359 | 0 | 0 |
| Selling & Marketing Expenses
| 367.114 | 341.328 | 357.631 | 370.217 | 255.135 | 176.967 | 104.177 | 0 | 0 |
| SG&A
| 484.976 | 466.843 | 502.423 | 524.903 | 716.586 | 191.659 | 112.536 | 83.258 | 64.399 |
| Other Expenses
| 69.538 | 107.668 | 54.177 | 34.539 | 18.43 | 13.573 | -0.007 | 0 | 0 |
| Operating Expenses
| 678.263 | 710.347 | 699.737 | 685.302 | 796.832 | 234.532 | 166.236 | 94.759 | 70.141 |
| Operating Income
| 65.846 | -27.007 | 11.012 | 13.406 | -275.719 | 139.676 | 77.251 | 50.307 | 18.917 |
| Operating Income Ratio
| 0.083 | -0.036 | 0.014 | 0.018 | -0.501 | 0.36 | 0.31 | 0.32 | 0.19 |
| Total Other Income Expenses Net
| -34.386 | -28.565 | -24.969 | -23.583 | -27.731 | -56.698 | -24.903 | -10.604 | -3.816 |
| Income Before Tax
| 31.46 | -55.572 | -23.231 | -10.177 | -303.45 | 82.978 | 52.348 | 39.703 | 15.101 |
| Income Before Tax Ratio
| 0.04 | -0.074 | -0.03 | -0.014 | -0.551 | 0.214 | 0.21 | 0.252 | 0.152 |
| Income Tax Expense
| 15.07 | -46.704 | 9.597 | 15.077 | -9.827 | 16.93 | 8.555 | 10.931 | 6.188 |
| Net Income
| 16.39 | -8.868 | -32.828 | -25.254 | -293.623 | 66.048 | 43.793 | 8.843 | -7.774 |
| Net Income Ratio
| 0.021 | -0.012 | -0.043 | -0.034 | -0.533 | 0.17 | 0.176 | 0.056 | -0.078 |
| EPS
| 0.12 | -0.022 | -0.08 | -0.063 | -0.75 | 0.11 | 0.12 | 0.023 | -0.02 |
| EPS Diluted
| 0.12 | -0.022 | -0.08 | -0.063 | -0.75 | 0.11 | 0.12 | 0.023 | -0.02 |
| EBITDA
| 153.92 | 108.824 | 68.538 | 48.004 | -257.107 | 148.27 | 84.347 | 59.406 | 28.006 |
| EBITDA Ratio
| 0.194 | 0.145 | 0.085 | 0.064 | -0.467 | 0.389 | 0.349 | 0.378 | 0.282 |